呼吸器感染症に対するcefetamet pivoxilの臨床効果の検討

DOI

書誌事項

タイトル別名
  • CEFETAMET PIVOXIL IN RESPIRATORY TRACT INFECTIONS

抄録

We investigated the clinical efficacy of cefetamet pivoxil (CEMT-PI), a new oral cephalosporin, in 13 patients with respiratory tract infections. CEMT-PI was given in a daily dose of 500mg, or 1, 000mg in 2 divided doses, for 7-15 days. Clinical efficacy was excellent in 7, good in 5 and fair in 1 patient. Slight elevations of GPT or GOT-EGPT were observed in 3 patients during the treatment, but no side effects were noted.

収録刊行物

詳細情報 詳細情報について

問題の指摘

ページトップへ